arrow_back Back to App

No Federal Funds for COVID-19 Tests from China

This bill aims to prohibit the use of taxpayer money to purchase at-home COVID-19 tests manufactured or imported from China. This means the federal government will not be able to acquire such tests, potentially affecting the availability and origin of tests provided to citizens.
Key points
Federal funds cannot be used to buy COVID-19 tests made in China.
The ban also applies to tests imported from China or manufactured by Chinese subsidiary companies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_6668
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2023-12-07
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

No Taxpayer Dollars for Communist China COVID Tests Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_6668.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-12-07.

What are the main provisions?

Key points include:

  • Federal funds cannot be used to buy COVID-19 tests made in China.
  • The ban also applies to tests imported from China or manufactured by Chinese subsidiary companies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Economy